Automation Hero Joins AWS Marketplace, Empowering End-to-end Intelligent Document Processing
Globe Newswire6-06-2023, 20:23
U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults 21-02-2026, 02:43